Neuroscientists at Australia's Macquarie University have developed a single-dose genetic drug that has been shown to halt the progression of both ALS and frontotemporal dementia (FTD)...
Researchers at the Sanders-Brown Center on Aging at the University of Kentucky recently Acta Neuropathologica Classified in 2019 and now known as LATE, it is the...
Recent Comments